Cara Therapeutics Inc. sell StockNews.com
Start price
12.10.24
/
50%
€0.23
Target price
12.10.25
-
Performance (%)
63.81%
End price
13.10.25
-
Summary
This prediction is currently being closed. The price for Cara Therapeutics Inc. has massively increased, which is bad news for the SELL prediction by StockNews_com. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cara Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 1,12 % | -1,55 % | 0,67 % |
| iShares Nasdaq 100 | 0,35 % | 9,67 % | 30,51 % |
| iShares Nikkei 225® | -1,41 % | 2,91 % | 42,71 % |
| iShares S&P 500 | 0,54 % | 4,77 % | 20,63 % |
Comments by StockNews_com for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CARA provided by MarketBeat
In the thread Trading Cara Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
17.02.24
17.02.24
-
17.02.25
17.02.25
-25.51%
18.02.25
18.02.25
